Published in BMJ on October 01, 2005
Efficacy of rectal misoprostol for prevention of postpartum hemorrhage. Iran J Pharm Res (2013) 1.98
Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. J R Soc Med (2012) 1.77
Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural India. Int J Gynaecol Obstet (2008) 1.49
Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial. BJOG (2015) 1.46
Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda. PLoS One (2015) 1.38
Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial. PLoS Med (2013) 1.32
What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG (2010) 1.31
Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ (2009) 1.29
Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial. BMC Pregnancy Childbirth (2012) 1.11
Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS One (2012) 1.05
Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet. J Midwifery Womens Health (2009) 1.03
Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it? Glob Health Action (2011) 1.02
Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health (2013) 1.02
Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study. BMJ (2010) 0.87
Different Doses of Sublingual Misoprostol versus Methylergometrine for the Prevention of Atonic Postpartum Haemorrhage. Int J Health Sci (Qassim) (2007) 0.85
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make? BMC Pregnancy Childbirth (2012) 0.81
The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial. BMC Pregnancy Childbirth (2015) 0.81
Do Health and Demographic Surveillance Systems benefit local populations? Maternal care utilisation in Butajira HDSS, Ethiopia. Glob Health Action (2014) 0.80
Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial. PLoS Med (2014) 0.79
Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh. BMC Pregnancy Childbirth (2014) 0.78
Formulation of ketotifen fumarate fast-melt granulation sublingual tablet. AAPS PharmSciTech (2010) 0.77
Postpartum haemorrhage: prevention. BMJ Clin Evid (2011) 0.76
Postpartum haemorrhage: prevention. BMJ Clin Evid (2008) 0.75
Measuring Post-Partum Haemorrhage in Low-Resource Settings: The Diagnostic Validity of Weighed Blood Loss versus Quantitative Changes in Hemoglobin. PLoS One (2016) 0.75
Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial. BMC Pregnancy Childbirth (2014) 0.75
A New Look at Care in Pregnancy: Simple, Effective Interventions for Neglected Populations. PLoS One (2016) 0.75
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet (2001) 5.25
An analysis of anemia and pregnancy-related maternal mortality. J Nutr (2001) 3.27
Nutrition and maternal mortality in the developing world. Am J Clin Nutr (2000) 2.65
Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod (2002) 2.55
Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev (2000) 2.26
Maternal mortality in Guinea-Bissau: the use of verbal autopsy in a multi-ethnic population. Int J Epidemiol (1999) 1.77
Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol (1998) 1.74
Accuracy of the blood loss estimation in the third stage of labor. Int J Gynaecol Obstet (2000) 1.43
Postpartum haemorrhage: its contribution to maternal mortality. Midwifery (1991) 1.27
Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstet Gynecol (1999) 1.26
Factors associated with maternal mortality in rural Guinea-Bissau. A longitudinal population-based study. BJOG (2002) 1.19
A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol (1998) 1.13
Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG (2002) 1.07
A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynecol Scand (2004) 1.06
Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial. S Afr Med J (2001) 0.99
Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res (2003) 7.22
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med (2009) 6.25
Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nat Biotechnol (2007) 6.21
Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07
A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol (2008) 4.55
Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci U S A (2005) 4.40
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
A community-driven global reconstruction of human metabolism. Nat Biotechnol (2013) 3.89
Socioeconomic and physical distance to the maternity hospital as predictors for place of delivery: an observation study from Nepal. BMC Pregnancy Childbirth (2004) 3.33
Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc Natl Acad Sci U S A (2003) 3.15
Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun (2012) 2.84
Reproducibility of oligonucleotide microarray transcriptome analyses. An interlaboratory comparison using chemostat cultures of Saccharomyces cerevisiae. J Biol Chem (2002) 2.72
Reduced in-hospital mortality after improved management of children under 5 years admitted to hospital with malaria: randomised trial. BMJ (2007) 2.71
Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut (2011) 2.67
DTP vaccination and child survival in observational studies with incomplete vaccination data. Trop Med Int Health (2007) 2.64
Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast (2005) 2.64
Changing pattern of malaria in Bissau, Guinea Bissau. Trop Med Int Health (2008) 2.54
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics (2013) 2.53
A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res (2012) 2.53
Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ (2010) 2.52
Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J (2012) 2.46
Growth-rate regulated genes have profound impact on interpretation of transcriptome profiling in Saccharomyces cerevisiae. Genome Biol (2006) 2.43
Large-scale evaluation of in silico gene deletions in Saccharomyces cerevisiae. OMICS (2003) 2.31
Evolutionary programming as a platform for in silico metabolic engineering. BMC Bioinformatics (2005) 2.31
Sibship characteristics and risk of allergic rhinitis and asthma. Am J Epidemiol (2005) 2.23
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ (2010) 2.18
Mass spectrometry in metabolome analysis. Mass Spectrom Rev (2005) 2.14
Modeling Lactococcus lactis using a genome-scale flux model. BMC Microbiol (2005) 2.14
Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries. Cell Mol Life Sci (2012) 2.06
Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res (2013) 2.05
Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial. Am J Clin Nutr (2009) 2.04
Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? Int J Epidemiol (2003) 2.03
Comparative genomics of citric-acid-producing Aspergillus niger ATCC 1015 versus enzyme-producing CBS 513.88. Genome Res (2011) 2.03
Genome-scale analysis of Streptomyces coelicolor A3(2) metabolism. Genome Res (2005) 2.03
Architecture of transcriptional regulatory circuits is knitted over the topology of bio-molecular interaction networks. BMC Syst Biol (2008) 2.02
The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLoS Comput Biol (2013) 2.00
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
In silico aided metabolic engineering of Saccharomyces cerevisiae for improved bioethanol production. Metab Eng (2005) 1.96
Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol (2012) 1.94
Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ (2008) 1.91
Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS (2008) 1.82
Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p. Proc Natl Acad Sci U S A (2009) 1.79
Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology (2007) 1.78
Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr (2007) 1.77
The genome-scale metabolic model iIN800 of Saccharomyces cerevisiae and its validation: a scaffold to query lipid metabolism. BMC Syst Biol (2008) 1.73
A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol (2013) 1.67
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine (2003) 1.65
Assessing the human gut microbiota in metabolic diseases. Diabetes (2013) 1.64
Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol (2008) 1.63
De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnology. Microb Cell Fact (2012) 1.62
OptFlux: an open-source software platform for in silico metabolic engineering. BMC Syst Biol (2010) 1.61
Integration of metabolome data with metabolic networks reveals reporter reactions. Mol Syst Biol (2006) 1.60
Integration of gene expression data into genome-scale metabolic models. Metab Eng (2004) 1.59
Mortality patterns during a war in Guinea-Bissau 1998-99: changes in risk factors? Int J Epidemiol (2005) 1.58
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Conflicting evidence for neonatal vitamin A supplementation. Vaccine (2008) 1.57
The 2008 update of the Aspergillus nidulans genome annotation: a community effort. Fungal Genet Biol (2008) 1.56
Why worry: vitamin A with DTP vaccine? Vaccine (2006) 1.56
A trispecies Aspergillus microarray: comparative transcriptomics of three Aspergillus species. Proc Natl Acad Sci U S A (2008) 1.56
Enhancing sesquiterpene production in Saccharomyces cerevisiae through in silico driven metabolic engineering. Metab Eng (2009) 1.55
BioMet Toolbox: genome-wide analysis of metabolism. Nucleic Acids Res (2010) 1.55
Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol (2004) 1.54
Sampling the solution space in genome-scale metabolic networks reveals transcriptional regulation in key enzymes. PLoS Comput Biol (2010) 1.52
Randomised study of effect of different doses of vitamin A on childhood morbidity and mortality. BMJ (2005) 1.50
The polio model. Does it apply to polio? Int J Epidemiol (2002) 1.49
Metabolic model integration of the bibliome, genome, metabolome and reactome of Aspergillus niger. Mol Syst Biol (2008) 1.47
High-throughput metabolic state analysis: the missing link in integrated functional genomics of yeasts. Biochem J (2005) 1.47
Reduced All-cause Child Mortality After General Measles Vaccination Campaign in Rural Guinea-Bissau. Pediatr Infect Dis J (2015) 1.45
Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J Infect Dis (2002) 1.45
Use of genome-scale microbial models for metabolic engineering. Curr Opin Biotechnol (2004) 1.45
Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J (2007) 1.44
Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol (2003) 1.44
TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis (2008) 1.44
The metabolic response of heterotrophic Arabidopsis cells to oxidative stress. Plant Physiol (2006) 1.43
Advanced life support in obstetrics (ALSO) and post-partum hemorrhage: a prospective intervention study in Tanzania. Acta Obstet Gynecol Scand (2011) 1.43
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis (2004) 1.43
Informed consent in medical decision-making in commercial gestational surrogacy: a mixed methods study in New Delhi, India. Acta Obstet Gynecol Scand (2015) 1.42
Survival bias in observational studies of the impact of routine immunizations on childhood survival. Trop Med Int Health (2007) 1.42
Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae. Yeast (2010) 1.41
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis (2010) 1.40
[Cesarean section on maternal request]. Ugeskr Laeger (2009) 1.39
Characterization of global yeast quantitative proteome data generated from the wild-type and glucose repression saccharomyces cerevisiae strains: the comparison of two quantitative methods. J Proteome Res (2008) 1.39
BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol (2005) 1.38
Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet (2003) 1.38
Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa. J Infect Dis (2002) 1.37
Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine (2005) 1.37
Leisure time physical activity during pregnancy and impact on gestational diabetes mellitus, pre-eclampsia, preterm delivery and birth weight: a review. Acta Obstet Gynecol Scand (2007) 1.36
Post-genomic insights into the plant polysaccharide degradation potential of Aspergillus nidulans and comparison to Aspergillus niger and Aspergillus oryzae. Fungal Genet Biol (2009) 1.35
Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ (2004) 1.33
Simultaneous analysis of amino and nonamino organic acids as methyl chloroformate derivatives using gas chromatography-mass spectrometry. Anal Biochem (2003) 1.33
Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open (2012) 1.33
Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology (2006) 1.29
The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine (2009) 1.28
Systems biology of antibiotic production by microorganisms. Nat Prod Rep (2007) 1.27
Establishing a platform cell factory through engineering of yeast acetyl-CoA metabolism. Metab Eng (2012) 1.27
A closer look at bacteroides: phylogenetic relationship and genomic implications of a life in the human gut. Microb Ecol (2011) 1.27